Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Multiomics analysis unveils an inosine-sensitive DNA damage response in neurogenic bladder after spinal cord injury
Ali Hashemi Gheinani, Bryan S. Sack, Alexander Bigger-Allen, Hatim Thaker, Hussein Atta, George Lambrinos, Kyle Costa, Claire Doyle, Mehrnaz Gharaee-Kermani, Susan Patalano, Mary Piper, Justin F. Cotellessa, Dijana Vitko, Haiying Li, Manubhai Kadayil Prabhakaran, Vivian Cristofaro, John Froehlich, Richard S. Lee, Wei Yang, Maryrose P. Sullivan, Jill A. Macoska, Rosalyn M. Adam
Ali Hashemi Gheinani, Bryan S. Sack, Alexander Bigger-Allen, Hatim Thaker, Hussein Atta, George Lambrinos, Kyle Costa, Claire Doyle, Mehrnaz Gharaee-Kermani, Susan Patalano, Mary Piper, Justin F. Cotellessa, Dijana Vitko, Haiying Li, Manubhai Kadayil Prabhakaran, Vivian Cristofaro, John Froehlich, Richard S. Lee, Wei Yang, Maryrose P. Sullivan, Jill A. Macoska, Rosalyn M. Adam
View: Text | PDF
Research Article Cell biology Muscle biology

Multiomics analysis unveils an inosine-sensitive DNA damage response in neurogenic bladder after spinal cord injury

  • Text
  • PDF
Abstract

Spinal cord injury (SCI) evokes profound dysfunction in hollow organs such as the urinary bladder and gut. Current treatments are limited by a lack of molecular data to inform novel therapeutic avenues. Previously, we showed that systemic treatment with the neuroprotective agent inosine improved bladder function following SCI in rats. Here, we applied integrated multi-omics analysis to explore molecular alterations in the bladder over time and their sensitivity to inosine following SCI. Canonical signaling pathways regulated by SCI included those associated with protein synthesis, neuroplasticity, wound healing, and neurotransmitter degradation. Upstream regulator and causal network analysis predicted multiple effectors of DNA damage response signaling following injury, including poly-ADP ribose phosphorylase-1 (PARP1). Markers of DNA damage (γH2AX, ATM/ATR substrates) and PARP activity were increased in bladder tissue following SCI and attenuated with inosine treatment. Inosine treatment also attenuated oxidative DNA damage in rat bladder cells in vitro. Proteomics analysis suggested that SCI induced changes in protein synthesis–, neuroplasticity-, and oxidative stress–associated pathways, a subset of which were shown in transcriptomics data to be inosine sensitive. These findings provide insights into the molecular landscape of the bladder following SCI and identify key inosine-sensitive pathways associated with injury.

Authors

Ali Hashemi Gheinani, Bryan S. Sack, Alexander Bigger-Allen, Hatim Thaker, Hussein Atta, George Lambrinos, Kyle Costa, Claire Doyle, Mehrnaz Gharaee-Kermani, Susan Patalano, Mary Piper, Justin F. Cotellessa, Dijana Vitko, Haiying Li, Manubhai Kadayil Prabhakaran, Vivian Cristofaro, John Froehlich, Richard S. Lee, Wei Yang, Maryrose P. Sullivan, Jill A. Macoska, Rosalyn M. Adam

×

Figure 8

In vitro validation of oxidative DNA damage and its sensitivity to inosine.

Options: View larger image (or click on image) Download as PowerPoint
In vitro validation of oxidative DNA damage and its sensitivity to inosi...
(A) Protein lysates of bladders harvested from rats at 2, 8, or 16 weeks following SCI or age-matched controls were assessed for malondialdehyde (MDA), a measure of lipid peroxidation (n = 3 biological replicates). (B) Expression of DNA damage–related genes in bladder tissue collected at the indicated times was assessed via qPCR (n = 4–6 biological replicates). (C) MDA was assessed in rat bladder fibroblasts treated ± H2O2 or PBS ± indicated doses of inosine (n = 3 biological replicates). (D) Immunoblot analysis of DNA damage–associated markers including phospho-ATM serine/threonine kinase (pATM), γH2AX, and Poly/Mono ADP Ribosylation (PAR) in rat bladder fibroblasts treated ± H2O2 or PBS ± indicated doses of inosine. (E) DNA damage was assessed by comet assay using rat bladder fibroblasts stimulated with 50 μM H2O2 ± indicated doses of inosine. Magnification, 20×. (F) Comet assay quantification, with 100–200 nuclei assessed for each condition. Data are representative of 3 independent trials. Significance was determined by 1-way ANOVA followed by Tukey’s multiple comparisons test. Adjusted P values were used to report the significance of the differences. *P < 0.05, **P < 0.01, versus control (Veh). #P < 0.05, ##P < 0.01, versus H2O2 50μM. $P < 0.05, $$P < 0.01, versus 1 mM inosine. &P < 0.05, versus 250 μM inosine.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts